MCID: CLL003
MIFTS: 59

Cellulitis

Categories: Immune diseases, Skin diseases

Aliases & Classifications for Cellulitis

MalaCards integrated aliases for Cellulitis:

Name: Cellulitis 12 29 55 43 44 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:3488
ICD10 33 L03.90 L03 L03.9
MeSH 44 D002481
SNOMED-CT 68 62837005 74276003

Summaries for Cellulitis

MedlinePlus : 43 Cellulitis is an infection of the skin and deep underlying tissues. Group A strep (streptococcal) bacteria are the most common cause. The bacteria enter your body when you get an injury such as a bruise, burn, surgical cut, or wound. Symptoms include Fever and chills Swollen glands or lymph nodes A rash with painful, red, tender skin. The skin may blister and scab over. Your health care provider may take a sample or culture from your skin or do a blood test to identify the bacteria causing infection. Treatment is with antibiotics. They may be oral in mild cases, or intravenous (by IV) for more severe cases. NIH: National Institute of Allergy and Infectious Diseases

MalaCards based summary : Cellulitis is related to wells syndrome and scleritis, and has symptoms including fever, pruritus and exanthema. An important gene associated with Cellulitis is TNF (Tumor Necrosis Factor), and among its related pathways/superpathways are Innate Immune System and Developmental Biology. The drugs Lincomycin and Clindamycin have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and breast, and related phenotypes are cellular and growth/size/body region

Disease Ontology : 12 A skin disease where there is a diffuse infection of connective tissue with severe inflammation of dermal and subcutaneous layers of the skin. Cellulitis can be caused by normal skin flora or by exogenous bacteria, and often occurs where the skin has previously been broken

Wikipedia : 76 Cellulitis is a bacterial infection involving the inner layers of the skin. It specifically affects the... more...

Related Diseases for Cellulitis

Diseases related to Cellulitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 402)
# Related Disease Score Top Affiliating Genes
1 wells syndrome 33.1 IL1R1 IL5 RNASE3
2 scleritis 30.1 IL5 TNF
3 pyoderma 29.9 DSG1 IL1R1 TNF
4 churg-strauss syndrome 29.7 IL5 RNASE3 TNF
5 keratoconjunctivitis 29.6 IL5 RNASE3 TNF
6 bronchiolitis 29.6 IL5 RNASE3 TNF
7 autoimmune disease 29.5 COL17A1 DSG1 IL5 TNF
8 keratosis 29.3 ATP2A2 DSG1 DSP
9 chronic granulomatous disease 29.2 CYBA CYBB NCF1 NCF2
10 pemphigus foliaceus 29.1 DSG1 DSG3 DST PPL
11 pemphigus vulgaris 28.6 DSC3 DSG1 DSG3 DSP DST PPL
12 pemphigus 28.6 ATP2C1 COL17A1 DSC3 DSG1 DSG3 DSP
13 bullous pemphigoid 28.3 COL17A1 DSG1 DSG3 DSP DST IL5
14 skin disease 27.7 ATP2A2 ATP2C1 COL17A1 DSC3 DSG1 DSG3
15 orbital cellulitis 12.5
16 perifolliculitis capitis abscedens et suffodiens, familial 12.1
17 tinea unguium 11.9
18 ludwig's angina 11.8
19 parametritis 11.4
20 erysipelas 11.4
21 lacrimal duct defect 11.3
22 erysipeloid 11.3
23 nocardiosis 11.3
24 lymphedema, hereditary, ia 11.0
25 lymphedema, hereditary, ii 11.0
26 whim syndrome 11.0
27 fusariosis 11.0
28 clear cell acanthoma 11.0
29 elizabethkingia anophelis infection 11.0
30 sinusitis 10.3
31 thrombosis 10.3
32 angioimmunoblastic lymphadenopathy with dysproteinemia 10.3 IL5 TNF
33 loeffler endocarditis 10.3 IL5 RNASE3
34 lichen planus pemphigoides 10.2 COL17A1 DST
35 lymphoma 10.2
36 vulvar vestibulitis syndrome 10.2 IL1R1 TNF
37 paronychia 10.2
38 cow milk allergy 10.2 IL5 RNASE3 TNF
39 paragonimiasis 10.2 IL5 RNASE3
40 erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige 10.2 DSG1 DSP
41 linear iga disease 10.2 COL17A1 DST
42 conjunctival disease 10.2 IL5 RNASE3 TNF
43 cough variant asthma 10.2 IL5 RNASE3
44 neurotic excoriation 10.2 COL17A1 DST
45 common cold 10.2 IL1R1 IL5 RNASE3
46 nose disease 10.2 IL5 RNASE3 TNF
47 cold urticaria 10.2 IL1R1 RNASE3
48 parasitic helminthiasis infectious disease 10.2 IL5 RNASE3 TNF
49 pemphigoid gestationis 10.2 COL17A1 DST IL5
50 upper respiratory tract disease 10.2 IL5 RNASE3 TNF

Graphical network of the top 20 diseases related to Cellulitis:



Diseases related to Cellulitis

Symptoms & Phenotypes for Cellulitis

UMLS symptoms related to Cellulitis:


fever, pruritus, exanthema

MGI Mouse Phenotypes related to Cellulitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.17 ATP2A2 ATP2C1 CYBA CYBB DSC3 DSG3
2 growth/size/body region MP:0005378 10.11 ATP2A2 ATP2C1 CYBB DSG1 DSG3 DSP
3 digestive/alimentary MP:0005381 10.06 ATP2A2 CYBA CYBB DSG3 DSP IL5
4 hematopoietic system MP:0005397 10.06 ATP2A2 CDH17 CYBA CYBB DSG3 IL1R1
5 immune system MP:0005387 10 ATP2A2 CDH17 CYBA CYBB DSG3 IL1R1
6 adipose tissue MP:0005375 9.93 CYBA CYBB DSG1 DSG3 IL1R1 TNF
7 integument MP:0010771 9.85 ATP2A2 ATP2C1 DSC3 DSG1 DSG3 DSP
8 neoplasm MP:0002006 9.43 ATP2A2 ATP2C1 CYBB IL1R1 IL5 TNF
9 respiratory system MP:0005388 9.28 ATP2A2 CYBA DSG3 IL1R1 IL5 LAMA3

Drugs & Therapeutics for Cellulitis

Drugs for Cellulitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 386)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lincomycin Approved, Vet_approved Phase 4 154-21-2 656509
2
Clindamycin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 18323-44-9 29029
3
Permethrin Approved, Investigational Phase 4,Not Applicable 52645-53-1 40326
4
Mupirocin Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 12650-69-0 446596
5
Cefazolin Approved Phase 4,Phase 3,Phase 2,Not Applicable 25953-19-9 656510 33255
6
Penicillin V Approved, Vet_approved Phase 4 87-08-1 6869
7
Vancomycin Approved Phase 4,Phase 2,Phase 3 1404-90-6 14969 441141
8
Daptomycin Approved, Investigational Phase 4,Phase 3,Phase 2 103060-53-3 16129629
9
Oxacillin Approved, Investigational Phase 4,Phase 3,Phase 2 66-79-5 6196
10
Cephalexin Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 15686-71-2 27447
11
Sulbactam Approved Phase 4 68373-14-8
12
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 26787-78-0 33613
13
Teicoplanin Approved, Investigational Phase 4,Phase 3 61036-62-2
14
Minocycline Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 10118-90-8 5281021
15
Tigecycline Approved Phase 4,Phase 3,Phase 2 220620-09-7 5282044
16
Sultamicillin Approved, Investigational Phase 4 76497-13-7
17
Ampicillin Approved, Vet_approved Phase 4 69-53-4 6249
18
Cefdinir Approved Phase 4 91832-40-5 6915944
19
Warfarin Approved Phase 4 81-81-2 6691 54678486
20
Oritavancin Approved, Investigational Phase 4,Phase 3,Phase 2 171099-57-3 16129632
21
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
22
Pimecrolimus Approved, Investigational Phase 4 137071-32-0 6447131 17753757
23
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 55-56-1 2713 9552079
24
Ivermectin Approved, Investigational, Vet_approved Phase 4,Not Applicable 70288-86-7 6474909
25
Azithromycin Approved Phase 4,Phase 3,Not Applicable 83905-01-5 55185 447043
26
Conivaptan Approved, Investigational Phase 4 210101-16-9 151171
27
Fondaparinux Approved, Investigational Phase 4 104993-28-4
28
Cloxacillin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 61-72-3 6098
29
Nafcillin Approved, Investigational Phase 4,Phase 2 985-16-0, 147-52-4 8982
30
Thrombin Approved, Investigational Phase 4
31
Petrolatum Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 8009-03-8
32
Dalbavancin Approved, Investigational Phase 4,Phase 3 91097-81-3, 171500-79-1 122186
33
Fusidic Acid Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 6990-06-3 3000226
34
Bacitracin Approved, Vet_approved Phase 4 1405-87-4 10909430 439542
35
Lenograstim Approved, Investigational Phase 4 135968-09-1
36
Pentoxifylline Approved, Investigational Phase 4 6493-05-6 4740
37
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
38
Serine Approved, Nutraceutical Phase 4 56-45-1 5951
39 Clindamycin palmitate Phase 4,Phase 2,Phase 3,Not Applicable
40 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
41 Clindamycin phosphate Phase 4,Phase 2,Phase 3,Not Applicable
42 Floxacillin Phase 4,Phase 3,Not Applicable
43 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
44 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
45 methicillin Phase 4,Phase 3,Phase 2,Not Applicable
46 Analgesics Phase 4,Phase 2,Phase 3,Not Applicable
47 Antirheumatic Agents Phase 4,Phase 3,Phase 2
48 Dermatologic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
49 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Not Applicable
50 Expectorants Phase 4,Phase 2,Phase 3

Interventional clinical trials:

(show top 50) (show all 400)
# Name Status NCT ID Phase Drugs
1 Adjunctive Clindamycin for Cellulitis: C4C Trial. Unknown status NCT01876628 Phase 4 Flucloxacillin and Clindamycin;Flucloxacillin and placebo
2 RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg Completed NCT00552799 Phase 4 Penicillin VK
3 Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas Completed NCT00295178 Phase 4 Daptomycin;Vancomycin
4 The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin Completed NCT01626560 Phase 4 Daptomycin;Vancomycin
5 Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections Completed NCT01549613 Phase 4 Daptomycin;Vancomycin
6 Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. Completed NCT00555061 Phase 4 Retapamulin Ointment, 1%
7 Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA Completed NCT01419184 Phase 4 Daptomycin;Vancomycin
8 Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections Completed NCT00352612 Phase 4 clindamycin;cephalexin
9 Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections Completed NCT00368537 Phase 4 Tigecycline;ampicillin-sulbactam
10 A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections Completed NCT00234949 Phase 4 cefdinir;cephalexin
11 Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis Completed NCT01064947 Phase 4 Retapamulin 1%
12 Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA Completed NCT02582203 Phase 4 Ceftaroline;Vancomycin
13 Study of Wound Packing After Superficial Skin Abscess Drainage Completed NCT00746109 Phase 4
14 A Study to Evaluate the Safety of a Single IV Dose of Orbactiv (Oritavancin) in Subjects on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Completed NCT02452918 Phase 4 Oritavancin
15 Comparison of the Effects of Cervical Vasopressin Versus no Premedication on Blood Loss During Vaginal Hysterectomy: A Randomized, Placebo Controlled Trial Completed NCT00799292 Phase 4 Vasopressin
16 Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis Completed NCT00121381 Phase 4 Pimecrolimus plus topical corticosteroid (TCS);Pimecrolimus vehicle (Placebo) plus topical corticosteroid (TCS)
17 Effect of Chlorhexidine Skin Cleansing on Skin Flora Completed NCT00198679 Phase 4 Chlorhexidine
18 Azithromycin - Ivermectin Mass Drug Administration for Skin Disease Completed NCT02775617 Phase 4 Ivermectin;Azithromycin;Permethrin
19 Use of Negative Pressure Wound Therapy in High Risk Surgical Closed Incisions Completed NCT02137447 Phase 4
20 Appendicectomy Skin Closure Technique: Changing Paradigms (ASC) Completed NCT02625987 Phase 4
21 A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia Completed NCT00435591 Phase 4 Conivaptan;placebo
22 World-wide Randomized Antibiotic Envelope Infection Prevention Trial Completed NCT02277990 Phase 4
23 The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty Completed NCT00909064 Phase 4 Fondaparinux Sodium (Arixtra)
24 Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections Completed NCT00711802 Phase 4 Daptomycin;Standard of Care (SOC)
25 Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty Completed NCT01410240 Phase 4 FLOSEAL Hemostatic Matrix + Standard of care
26 Topical Therapy for Prevention of Infections in Preterm Infants Completed NCT00162747 Phase 4 Aquaphor;Sunflower Seed Oil
27 Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection Completed NCT01126268 Phase 4 Retapamulin (Altabax)
28 Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence Recruiting NCT02566928 Phase 4 2% mupirocin ointment
29 GCSF in Alcoholic Hepatitis Recruiting NCT03703674 Phase 4 GCSF
30 G-CSF Plus NAC In Severe Alcoholic Hepatitis Recruiting NCT02971306 Phase 4 standard medical therapy;G-CSF;n-Acetylcysteine
31 Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections Recruiting NCT03426761 Phase 4 Dalbavancin;Vancomycin
32 Group A Pharyngitis in Children: The GASPARD Study Recruiting NCT03264911 Phase 4 Amoxicillin or Placebo
33 Penicillin for the Emergency Department Outpatient Treatment of CELLulitis Not yet recruiting NCT02922686 Phase 4 Flucloxacillin;Phenoxymethylpenicillin;Placebo (for phenoxymethylpenicillin)
34 Hospital Avoidance Strategies for ABSSSI Not yet recruiting NCT03372941 Phase 4 Dalbavancin
35 Duration of ANtibiotic Therapy for CEllulitis Terminated NCT02032654 Phase 4 Flucloxacillin;Placebo (for flucloxacillin)
36 Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections Terminated NCT00463801 Phase 4 Daptomycin
37 Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section Terminated NCT01528696 Phase 4
38 Local Application of Vancomycin Powder in Grade I-IIIA Open Fractures Terminated NCT02400112 Phase 4 Vancomycin
39 Fucidin® Cream in the Treatment of Impetigo Terminated NCT00986856 Phase 4 Fucidin® cream
40 Use of Santyl Within an Accountable Care Organization Withdrawn NCT02716519 Phase 4
41 Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department Unknown status NCT00323219 Phase 3 Cefazolin and Moxifloxacin
42 Citriodiol® and Impetigo Unknown status NCT01611909 Phase 2, Phase 3 p-menthane-3,8-diol oil
43 A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection Completed NCT00560599 Phase 3 mupirocin and chlorhexidine;mupirocin, chlorhexidine, & household cleaning/disinfection
44 Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections Completed NCT01400867 Phase 2, Phase 3 Ceftaroline fosamil;Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam;Cephalexin or Clindamycin or Linezolid
45 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Completed NCT00424190 Phase 3 IV Vancomycin plus IV Aztreonam;Ceftaroline
46 Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections Completed NCT00423657 Phase 3 ceftaroline;vancomycin plus aztreonam;Placebo
47 Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA Completed NCT00852540 Phase 3 Retpamulin Ointment, 1%;Linezolid
48 Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) Completed NCT00684177 Phase 3 Retapamulin Ointment, 1%;Placebo ointment
49 A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections Completed NCT00249197 Phase 3 levofloxacin
50 China Registration Study in Patients With Skin Infections Completed NCT00772447 Phase 3 Daptomycin;Vancomycin

Search NIH Clinical Center for Cellulitis

Cochrane evidence based reviews: cellulitis

Genetic Tests for Cellulitis

Genetic tests related to Cellulitis:

# Genetic test Affiliating Genes
1 Cellulitis 29

Anatomical Context for Cellulitis

MalaCards organs/tissues related to Cellulitis:

41
Skin, Testes, Breast, Lymph Node, T Cells, Colon, Kidney

Publications for Cellulitis

Articles related to Cellulitis:

(show top 50) (show all 1584)
# Title Authors Year
1
Systemic corticosteroids may be beneficial for managing severe or refractory orbital cellulitis in children. ( 29920768 )
2018
2
Non-invasive assessment of cellulitis from snapshot hyperspectral imaging - A primary study. ( 29368433 )
2018
3
Indicators for imaging in periorbital cellulitis secondary to rhinosinusitis. ( 29450710 )
2018
4
Management of pediatric orbital cellulitis: A systematic review. ( 29859573 )
2018
5
Cellulitis: what to measure, how to define? Systematic review of outcomes from cellulitis trials. ( 29785809 )
2018
6
Tinea capitis mimicking dissecting cellulitis in three children. ( 29265536 )
2018
7
Clinical characteristics affecting length of stay in patients with cellulitis. ( 29415341 )
2018
8
Orbital Cellulitis ( 29939678 )
2018
9
A case report of orbital Langerhans cell histiocytosis presenting as a orbital cellulitis. ( 29643005 )
2018
10
Orbital cellulitis secondary to a fungal sinusitis caused by Scopulariopsis: The first case in Tunisia. ( 29709267 )
2018
11
Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer. ( 29128228 )
2018
12
Non-tender recurrent scrotal cellulitis. ( 29440333 )
2018
13
Orbital Cellulitis-When Computed Tomography Imaging Is Falsely Reassuring. ( 29768298 )
2018
14
Temporal Expression of Genes in Biofilm-Forming Ocular Candida albicans Isolated From Patients With Keratitis and Orbital Cellulitis. ( 29372251 )
2018
15
Seasonality of cellulitis: evidence from Google Trends. ( 29765240 )
2018
16
Patient factors associated with nationwide emergency department utilization for cellulitis. ( 29958742 )
2018
17
Group B Streptococcal Cellulitis and Necrotizing Fasciitis in Infants: A Systematic Review. ( 29424798 )
2018
18
Recurrent Cellulitis in a Patient with Papillomatosis Cutis Lymphostatica. ( 29849304 )
2018
19
Langerhans cell histiocytosis in an 18-month-old child presenting as periorbital cellulitis. ( 29755272 )
2018
20
Cellulitis and Bacteremia due to <i>Neisseria weaveri</i> following a dog bite. ( 29942750 )
2018
21
Estimating the health care costs associated with recurrent cellulitis managed in the outpatient setting. ( 29428738 )
2018
22
Wells syndrome (eosinophilic cellulitis) caused by adrenal insufficiency and relieved by cortisone supplementation. ( 29398098 )
2018
23
Dissecting Cellulitis of the Scalp: A Rare Dermatological Manifestation of Crohn's Disease. ( 29430467 )
2018
24
Disseminated cryptococcosis presenting initially as lower limb cellulitis in a renal transplant recipient - a case report. ( 29374464 )
2018
25
The epidemiology and risk factors for recurrent severe lower limb cellulitis: a longitudinal cohort study. ( 29427799 )
2018
26
Incidence of Cellulitis among Children with Primary Lymphedema. ( 29791815 )
2018
27
Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom. ( 29867431 )
2018
28
Saksenaea vasiformis Orbital Cellulitis in an Immunocompetent Child Treated With Posaconazole. ( 29522137 )
2018
29
Cellulitis caused by the Burkholderia cepacia complex associated with contaminated chlorhexidine 2% scrub in five domestic cats. ( 29877147 )
2018
30
Nasal septal abscess as a sequela of orbital cellulitis: An uncommon presentation. ( 29899988 )
2018
31
Fifteen-minute consultation: Preseptal and orbital cellulitis. ( 29934359 )
2018
32
Treatment of a Klebsiella pneumoniae KPC cellulitis and gut decolonization with ceftazidime/avibactam in a migrant from Libya. ( 29336224 )
2018
33
Orbital Cellulitis from an Orbital Compressed Air and Diesel Explosion Injury. ( 29611376 )
2018
34
Eosinophilic infiltrate resembling eosinophilic cellulitis (Wells syndrome) in a patient with mycosis fungoides. ( 29469767 )
2018
35
Clostridium perfringens panophthalmitis and orbital cellulitis: a case report. ( 29631556 )
2018
36
Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control study. ( 29427797 )
2018
37
Orbital apex syndrome from bacterial sinusitis without orbital cellulitis. ( 29468204 )
2018
38
<i>Shewanella</i> cellulitis and bacteremia following marine water exposure. ( 29942773 )
2018
39
Scleredema Diabeticorum with Superimposed Cellulitis and Abscess Formation. ( 29850291 )
2018
40
Ulcerative cellulitis of the arm: a case of primary cutaneous cryptococcosis. ( 29630156 )
2018
41
Eosinophilic cellulitis (Wells syndrome) successfully treated with mepolizumab. ( 29892672 )
2018
42
Trigeminal Trophic Syndrome Leading to Orbital Cellulitis. ( 29849238 )
2018
43
Erratum: Extranodal natural killer/T cell lymphoma, nasal type presenting as recurrent facial cellulitis. ( 29451197 )
2018
44
Hospital cost analysis of children with preseptal cellulitis. ( 29447901 )
2018
45
Variation in Care and Clinical Outcomes in Children Hospitalized With Orbital Cellulitis. ( 29208694 )
2018
46
Mass Compression from Recurrent Lymphoma Mimicking Lower Extremity Cellulitis. ( 29900086 )
2018
47
Cellulitis and Soft Tissue Infections. ( 29404597 )
2018
48
Acute dacryocystitis complicated by orbital cellulitis and loss of vision: A case report and review of the literature. ( 30118963 )
2018
49
Clinical and trichoscopic correlation of primary neutrophilic scarring alopecia: folliculitis decalvans and dissecting cellulitis. ( 30229638 )
2018
50
Two Cases of Micro-Arteriovenous Fistula in the Lower Extremity with Misdiagnosis of Refractory Cellulitis. ( 29682125 )
2018

Variations for Cellulitis

Expression for Cellulitis

Search GEO for disease gene expression data for Cellulitis.

Pathways for Cellulitis

Pathways related to Cellulitis according to GeneCards Suite gene sharing:

(show all 24)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.88 CYBA CYBB DSG1 DSP IL1R1 IL5
2
Show member pathways
13.37 DSC3 DSG1 DSG3 DSP IL5 PPL
3
Show member pathways
12.32 CYBA CYBB NCF1 NCF2
4
Show member pathways
12.31 CYBA CYBB NCF1 NCF2
5
Show member pathways
12.29 DSC3 DSG1 DSG3 DSP PPL
6
Show member pathways
12.18 CYBA CYBB NCF1 NCF2
7
Show member pathways
12.02 COL17A1 CYBA CYBB IL1R1 LAMA3 NCF1
8 11.99 CYBA CYBB NCF1 NCF2
9 11.87 CYBA CYBB NCF1 NCF2
10
Show member pathways
11.85 DSG1 DSG3 DSP
11
Show member pathways
11.81 DSP DST PPL
12 11.8 CYBA IL1R1 NCF1 NCF2 TNF
13 11.75 IL1R1 IL5 TNF
14 11.74 IL1R1 LAMA3 TNF
15
Show member pathways
11.7 CYBA CYBB LAMA3 NCF1 NCF2 TNF
16
Show member pathways
11.67 CYBA CYBB NCF1 NCF2
17 11.66 CYBA IL1R1 NCF1 NCF2 TNF
18 11.64 IL1R1 IL5 TNF
19 11.5 DSP IL5 TNF
20
Show member pathways
11.36 CYBA CYBB NCF1 NCF2
21 11.18 CYBA CYBB NCF1 NCF2
22 10.89 LAMA3 TNF
23 10.84 CDH17 COL17A1 IL5 LAMA3 NCF2 TNF
24 10.04 CYBA CYBB NCF1 NCF2

GO Terms for Cellulitis

Cellular components related to Cellulitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell junction GO:0030054 9.86 CDH17 COL17A1 DSC3 DSG1 DSG3 DSP
2 cell-cell junction GO:0005911 9.71 COL17A1 DSC3 DSG1 DSP
3 basement membrane GO:0005604 9.65 COL17A1 DST LAMA3
4 cornified envelope GO:0001533 9.55 DSC3 DSG1 DSG3 DSP PPL
5 hemidesmosome GO:0030056 9.43 COL17A1 DST
6 phagolysosome GO:0032010 9.32 NCF1 NCF2
7 NADPH oxidase complex GO:0043020 9.26 CYBA CYBB NCF1 NCF2
8 desmosome GO:0030057 9.02 DSC3 DSG1 DSG3 DSP PPL
9 membrane GO:0016020 10.33 ATP2A2 ATP2C1 CDH17 COL17A1 CYBA CYBB
10 plasma membrane GO:0005886 10.18 CDH17 COL17A1 CYBA CYBB DSC3 DSG1

Biological processes related to Cellulitis according to GeneCards Suite gene sharing:

(show all 22)
# Name GO ID Score Top Affiliating Genes
1 innate immune response GO:0045087 9.98 CYBA CYBB NCF1 NCF2 RNASE3
2 cell adhesion GO:0007155 9.98 ATP2A2 CDH17 DSC3 DSG1 DSG3 DST
3 neutrophil degranulation GO:0043312 9.97 CYBA CYBB DSG1 DSP RNASE3
4 inflammatory response GO:0006954 9.96 CYBA CYBB IL1R1 IL5 TNF
5 homophilic cell adhesion via plasma membrane adhesion molecules GO:0007156 9.85 CDH17 DSC3 DSG1 DSG3
6 keratinization GO:0031424 9.85 DSC3 DSG1 DSG3 DSP PPL
7 wound healing GO:0042060 9.78 DSP DST PPL
8 electron transport chain GO:0022900 9.78 CYBA CYBB NCF1 NCF2
9 cellular response to oxidative stress GO:0034599 9.77 ATP2A2 CYBA CYBB
10 cornification GO:0070268 9.72 DSC3 DSG1 DSG3 DSP PPL
11 calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules GO:0016339 9.71 ATP2C1 CDH17 DSG1
12 vascular endothelial growth factor receptor signaling pathway GO:0048010 9.71 CYBA CYBB NCF1 NCF2
13 intermediate filament cytoskeleton organization GO:0045104 9.67 DSP DST PPL
14 epidermis development GO:0008544 9.65 ATP2A2 ATP2C1 COL17A1 DSP LAMA3
15 positive regulation of podosome assembly GO:0071803 9.59 IL5 TNF
16 hydrogen peroxide biosynthetic process GO:0050665 9.57 CYBA CYBB
17 hemidesmosome assembly GO:0031581 9.54 COL17A1 DST LAMA3
18 cellular response to L-glutamine GO:1904845 9.52 CYBA CYBB
19 response to aldosterone GO:1904044 9.51 CYBA CYBB
20 superoxide metabolic process GO:0006801 9.46 CYBA CYBB NCF1 NCF2
21 respiratory burst GO:0045730 9.26 CYBA CYBB NCF1 NCF2
22 superoxide anion generation GO:0042554 8.92 CYBA CYBB NCF1 NCF2

Molecular functions related to Cellulitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 calcium ion binding GO:0005509 9.63 ATP2A2 CDH17 DSC3 DSG1 DSG3 DST
2 structural molecule activity GO:0005198 9.56 DSP DST LAMA3 PPL
3 proton-exporting ATPase activity, phosphorylative mechanism GO:0008553 9.4 ATP2A2 ATP2C1
4 calcium-transporting ATPase activity GO:0005388 9.37 ATP2A2 ATP2C1
5 superoxide-generating NADPH oxidase activator activity GO:0016176 9.32 NCF1 NCF2
6 electron transfer activity GO:0009055 9.26 CYBA CYBB NCF1 NCF2
7 superoxide-generating NADPH oxidase activity GO:0016175 8.92 CYBA CYBB NCF1 NCF2

Sources for Cellulitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....